For example, not all adverse AML were ABCB1 high, not all mutant NPM1 AML were ABCB1 low and a majority of CEBPA mutant AML were ABCB1 high despite CEBPa being a favorable prognostic marker. Here, NPM1 is linked to acute myeloid leukemia.